Table 4.
Ligand | R | MC4R Binding Ki (nM) |
MC4R EC50 (nM)
(Intrinsic Activity) |
||
cAMP Accumulation | Calcium Mobilization | Internalization | |||
α-MSH * | Acetyl-SYSMEHFRWGKPV-amide | 50.1 | 21.4 (100) |
129 (100) |
28.8 (100) |
β-MSH * | DEGPYRMEHFRWGSPPKD | 18.6 | 11.2 (83) |
174 (94) |
43.7 (118) |
γ-MSH * | YVMGHFRWDRFG | 589 | 631 (80) |
>1000 (62) |
>1000 (75) |
des-acetyl-α-MSH | SYSMEHFRWGKPV-amide | 30.2 | 17.4 (84) |
110 (96) |
30.2 (107) |
NDP-α-MSH | Acetyl-SYS(Nle)H(D-Phe)-RWGKPV-amide | 3.98 | 1.38 (112) |
120 (80) |
7.24 (89) |
THIQ | 10.7 | 1.32 (98) |
692 (7) |
0.81 (29) ** |
|
NBI-55886 | 9.55 | 331 (73) |
>1000 (40) |
3.47 (16) ** |
|
NBI-56297 | 20 | 129 (81) |
>1000 (23) |
7.94 (−5) ** |
|
NBI-56453 | 74.1 | 513 (103) |
45.7 (7) |
5.25 (27) ** |
|
NBI-58702 | 6.31 | 43 (110) |
2.4 (20) |
7.59 (38) ** |
|
NBI-58704 | 13.5 | 204 (149) |
17.8 (23) |
145 (34) ** |
* Endogenous melanocortin receptor-4 agonist. ** For all the small molecules, the intrinsic activity for internalization was significantly different and lower than that in the cAMP accumulation assay.